51
Howard Murad: Pharmaceutical compositions and methods for protecting and treating sun damaged skin. Pennie & Edmonds, September 8, 1998: US05804168 (85 worldwide citation)

This invention relates to a pharmaceutical composition for the protection and prevention of skin damage to a patient resulting from exposure to sunlight having at least one antioxidant component in an amount sufficient to inhibit the formation of free radicals; at least one anti-inflammatory compone ...


52
Robert S Osbakken, Mary Anne Hale, Frederick T Leivo, James D Munk: Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis. SinusPharma, Dale L Rieger, Stephanie L Seidman, Heller Ehrman White & McAuliffe, June 10, 2003: US06576224 (82 worldwide citation)

Pharmaceutical compositions are described that comprise one or more active ingredients selected from the group consisting of anti-infective, anti-inflammatory and mucolytic agents, and particularly to compositions formulated as a solution in a unit dose for aerosol administration to treat chronic si ...


53
Donald L Bissett, Rodney D Bush, Ranjit Chatterjee: Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent. The Procter & Gamble Company, Milton B Graff IV, Gretchen R Hatfield, Steven J Goldstein, July 11, 1989: US04847071 (82 worldwide citation)

Disclosed are pharmaceutical compositions comprising tocopherol sorbate and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of tocopherol sorbate, an anti-inflammatory agent, and a sunscreen are also d ...


54
Prasit Petpiboon, Fortin Rejean, Hutchinson John H, Belley Michel L, Leger Serge, Gillard John, Frenette Richard: (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes.. Merck Frosst Canada, March 27, 1991: EP0419049-A1 (82 worldwide citation)

Compounds having the formula I: are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labo ...


55
Anderson Donald Carroll, Rothlein Robert, Smith Clinton Wayne, Barton Randall Wilbur: Use of icam-1 or its functional derivatives for the treatment of non-specific inflammation.. Baylor College Medicine, Boehringer Ingelheim Pharma, May 10, 1989: EP0314863-A2 (81 worldwide citation)

The invention provides a method for treating inflammation caused by the non-specific defense system of a mammalian subject. Inflammation is treated by providing the subject with an anti-inflammatory agent capable of inhibiting granulocyte-endothelial cell adhesion.


56
Bret A Ferree: Natural and synthetic supplements to engineered annulus and disc tissues. Gifford Krass Groh Sprinkle Anderson & Citkowski PC, November 18, 2003: US06648920 (81 worldwide citation)

Fibrocytes, annulus fibrosis cells, cells that differentiate into annulus fibrosis cells, or cells that function like annulus fibrosis cells are harvested and combined with the extracellular matrix of the annulus fibrosis from a recently deceased human or animal to produce an engineered annulus fibr ...


57
Annette Skinhøj, Poul Bertelsen: Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs). Nycomed Danmark, Peter F Corless, Christine C O&apos Day, Edwards & Angell, July 29, 2003: US06599529 (79 worldwide citation)

An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug substance to obtain both a relatively fast onset of the therapeutic effect and the maintenance of a therapeu ...


58
Ohtori Akira, Andoh Masako, Morita Yasushi: A controlled-release pharmaceutical preparation for intra-ocular implant.. Senju Pharma Co, June 3, 1992: EP0488401-A1 (79 worldwide citation)

Presented are a controlled-release pharmaceutical preparation for intra-ocular implant to be applied to the interior of the eye after a surgical operation for disorders in retina/vitreous body or for glaucoma, which is produced by homogeneously dispersing an anti-inflammatory agent or a cell prolife ...


59
Raffa Robert B: Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug.. Mcneilab, June 16, 1993: EP0546676-A1 (79 worldwide citation)

This invention relates to a composition comprising a tramadol material and a nonsteroidal antiinflammatory drug, and its use. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, ...


60
John T Dingle, John L Gordon, Geraint Jones, Clive G Knight, John S Lowe: Pharmaceutical compositions. Imperial Chemical, National Research Development Corporation, Cushman Darby & Cushman, January 24, 1984: US04427649 (78 worldwide citation)

Pharmaceutical liposome compositions containing an anti-inflammatory steroid derivative bearing a lipophilic substituent, for example cortisol 21-hexadecanoate. Method of treatment of inflammation at a site involving an enclosed cavity, for example the treatment of rheumatic disease, comprising inje ...



Click the thumbnails below to visualize the patent trend.